FAS and autoimmune lymphoproliferative syndrome: Our results indicate that with a proper approach, genetic assessment of somatic FAS variants in ALPS patients can be performed at any time over the clinical course, as immunosuppressive treatment did not eliminate all mutated cells, although their numbers in peripheral blood were considerably reduced.